Overview
Capillary malformation-arteriovenous malformation (CM-AVM) is a rare inherited vascular disorder characterized by the presence of multiple small, round, pinkish-red capillary malformations (CMs) scattered across the skin, often surrounded by a pale halo. These cutaneous lesions are typically present from birth and can be found on the face, limbs, and trunk. A significant proportion of affected individuals—estimated at approximately 30%—also develop fast-flow vascular lesions, including arteriovenous malformations (AVMs) or arteriovenous fistulas (AVFs), which can occur in the brain, spine, skin, muscle, or bone. These fast-flow lesions carry a risk of serious complications such as hemorrhage, heart failure, or neurological deficits depending on their location. CM-AVM is caused by heterozygous loss-of-function mutations in the RASA1 gene (CM-AVM1, also known as CM-AVM syndrome type 1) or the EPHB4 gene (CM-AVM2, CM-AVM syndrome type 2). Both genes encode proteins involved in the RAS/MAPK signaling pathway, which plays a critical role in blood vessel development and maintenance. The condition follows autosomal dominant inheritance with variable expressivity and incomplete penetrance, meaning that family members carrying the same mutation may have very different clinical presentations. Diagnosis is based on clinical findings and confirmed through molecular genetic testing. Management requires a multidisciplinary approach involving dermatologists, interventional radiologists, neurologists, and vascular surgeons. Screening for intracranial and spinal AVMs is recommended, particularly in children, given the risk of life-threatening bleeding. Treatment of AVMs may include embolization or surgical excision depending on the size, location, and symptoms. Capillary malformations themselves are generally benign and may be treated with pulsed dye laser therapy for cosmetic purposes. There is currently no cure, and management focuses on surveillance and treatment of complications.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Capillary malformation-arteriovenous malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Capillary malformation-arteriovenous malformation at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Capillary malformation-arteriovenous malformation.
Community
No community posts yet. Be the first to share your experience with Capillary malformation-arteriovenous malformation.
Start the conversation →Latest news about Capillary malformation-arteriovenous malformation
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Capillary malformation-arteriovenous malformation
What is Capillary malformation-arteriovenous malformation?
Capillary malformation-arteriovenous malformation (CM-AVM) is a rare inherited vascular disorder characterized by the presence of multiple small, round, pinkish-red capillary malformations (CMs) scattered across the skin, often surrounded by a pale halo. These cutaneous lesions are typically present from birth and can be found on the face, limbs, and trunk. A significant proportion of affected individuals—estimated at approximately 30%—also develop fast-flow vascular lesions, including arteriovenous malformations (AVMs) or arteriovenous fistulas (AVFs), which can occur in the brain, spine, ski
How is Capillary malformation-arteriovenous malformation inherited?
Capillary malformation-arteriovenous malformation follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Capillary malformation-arteriovenous malformation typically begin?
Typical onset of Capillary malformation-arteriovenous malformation is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Capillary malformation-arteriovenous malformation?
20 specialists and care centers treating Capillary malformation-arteriovenous malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.